Abbeville General Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• NRG Oncology2 trials

Running trials

• Recruiting

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· Phase 3· NRG Oncology· Source

  Contact: Michelle M. Loch (principal investigator)

• Recruiting

  Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  NCT05174169· Phase 2/3· NRG Oncology· Source

  Contact: Augusto C. Ochoa (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Ovarian cancer1 recruiting